BIOMAT Database Logo BIOMAT Database Logo

[Extrapyramidal symptoms due to calcinosis cerebri in a patient with unknown primary hypoparathyroidism]. 2012

Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas

UI MeSH Term Description Entries
D007011 Hypoparathyroidism A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone. Idiopathic Hypoparathyroidism,Hypoparathyroidism, Idiopathic
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001928 Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function. Central Nervous System Metabolic Disorders,Encephalopathies, Metabolic,Metabolic Disorders, Brain,Acquired Metabolic Diseases, Brain,Acquired Metabolic Diseases, Nervous System,Acquired Metabolic Encephalopathies,Brain Diseases, Metabolic, Acquired,Brain Disorders, Metabolic,Brain Disorders, Metabolic, Acquired,Brain Syndrome, Metabolic,Brain Syndrome, Metabolic, Acquired,CNS Metabolic Disorders,CNS Metabolic Disorders, Acquired,Encephalopathy, Metabolic, Acquired,Metabolic Brain Diseases,Metabolic Brain Diseases, Acquired,Metabolic Brain Syndrome,Metabolic Brain Syndrome, Acquired,Metabolic Brain Syndromes,Metabolic Brain Syndromes, Acquired,Metabolic Diseases, Acquired, Nervous System,Metabolic Disorder, Central Nervous System, Acquired,Metabolic Disorders, CNS,Metabolic Disorders, CNS, Acquired,Metabolic Disorders, Central Nervous System,Metabolic Encephalopathies,Nervous System Acquired Metabolic Diseases,Acquired Metabolic Encephalopathy,Brain Disease, Metabolic,Brain Disorder, Metabolic,Brain Metabolic Disorder,Brain Metabolic Disorders,CNS Metabolic Disorder,Encephalopathies, Acquired Metabolic,Encephalopathy, Acquired Metabolic,Encephalopathy, Metabolic,Metabolic Brain Disease,Metabolic Brain Disorder,Metabolic Brain Disorders,Metabolic Disorder, Brain,Metabolic Disorder, CNS,Metabolic Encephalopathies, Acquired,Metabolic Encephalopathy,Metabolic Encephalopathy, Acquired
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions

Related Publications

Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
Brain calcinosis in a dialysis patient with hypoparathyroidism.
February 2008, NDT plus,
Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
[Familial, idiopathic hypoparathyroidism with intracerebral calcifications and extrapyramidal symptoms].
May 1977, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
Calcinosis cutis in a patient with primary hyperoxaluria due to hepatic enzyme deficiency.
October 2001, The Journal of dermatology,
Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
Rhabdomyolysis in a patient with hypocalcemia due to hypoparathyroidism.
January 1993, American journal of nephrology,
Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
Symptomatic striopallidodentate calcinosis (Fahr's syndrome) in a thalassemic patient with hypoparathyroidism.
May 2015, Annals of hematology,
Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
Extrapyramidal symptoms in a patient treated with fluvoxamine.
April 1992, Journal of neurology, neurosurgery, and psychiatry,
Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
Primary hypoparathyroidism in a cat complicated by suspect iatrogenic calcinosis cutis.
January 2001, Journal of the American Animal Hospital Association,
Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
Generalized tonic-clonic seizures in a thalassemic patient with hypoparathyroidism and brain calcinosis.
March 2011, Pediatric endocrinology reviews : PER,
Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
[EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
October 1963, Fortschritte der Neurologie, Psychiatrie, und ihrer Grenzgebiete,
Joana Nicolau Ramis, and Ana Espino Ibáñez, and Rosmeri Rivera Irigoín, and Carla Francés Artigas, and Luis Masmiquel Comas
Extrapyramidal symptoms in patients with primary degenerative dementia.
November 1981, Journal of clinical psychopharmacology,
Copied contents to your clipboard!